New technology news: "Off-label" use of dermatological device to cut body fat
Credentialing Resource Center Connection, April 1, 2010
Want to receive articles like this one in your inbox? Subscribe to Credentialing Resource Center Connection!
Practitioners across the country are beginning to find an “off-label” use for a device which has been approved by the FDA for cooling skin during dermatological procedures. They are using the Zeltiq device to remove body fat through a freezing process, according to a March 29 Boston Globe article.
Although other countries have approved Zeltiq for fat reduction purposes, the FDA has not. Practitioners are allowed to use the device for “off-label” purposes, meaning a process other than ones it is being marketed for, but the manufacture is not allowed to market it for those purposes.
It is a best practice for medical staffs to know whether practitioners are using devices for their FDA-approved purposes or in an “off-label” way.
Want to receive articles like this one in your inbox? Subscribe to Credentialing Resource Center Connection!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- HIPAA Q&A: Level of encryption needed for email
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: Level of encryption needed for email
- Q&A: Follow CMS' coding guidelines when using modifier -25
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- CMS has reformulated payments for some bilateral procedures
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- ED-to-inpatient transfers are flawed with safety gaps
- Searched
